Anhui Pioneer Pharmaceutical Co., Ltd, founded in Jan 2004, is a pharmaceutical enterprise which engages in pharmaceutical research and development, drug manufacturing, and international trade. It locates in Hefei of China, covering an area of about 20000 square meters .
Pioneer has several advanced production lines for injections, capsules, tablets, granules with Chinese GMP certificates. Now the company has six production workshops: one freeze-drying powder for injection workshop（annual capacity: 50million vials）; One common powder for injection workshop (annual capacity: 100million vials); one independent cephalosporin for injection workshop (annual capacity: 60 million vials); two oral solid workshops and a plant extraction workshop (annual capacity: 250 million tablets; 250 million capsules; 10 million sachets of granules).
The company has about 300 staff, among which about 30 are research staff. Two research centers have been founded, one located in Hefei, and the other located in Shanghai，and a set of technological innovation system has also been established. Our company was identified by the Department of Science and Technology of Anhui Province as a "High-Tech Enterprise" in 2012.
Pioneer has established an independent, strict and sound quality management system in accordance with Chinese GMP and ISO9001, the quality department is consisted of QA and QC. QA is responsible for the supervision of the quality during the production to ensure that production is operated in accordance with GMP and product quality meets the required specifications. QC is equipped with state-of-the-art devices, ensuring the high quality of raw materials, in process intermediates and final drug products, packaging materials, etc.
Now there are over 20 drug products, for both US and China market, in our ANDA product development pipeline, and we are preparing for the US FDA inspection.
Pioneer obtained certificates in quality, environment, occupational health and safety management: ISO9001-2015、ISO14001-2015 、GB/T28001-2011/OHSAS18001:2007.
We look forward to establishing long-term business relations with your company and promoting mutual development.